Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
Abstract
We have described a murine model of IBD that was induced in C.B-17 scid mice by transfer of the CD45RBhi subpopulation of CD4+ T cells from normal BALB/c mice and could be prevented by cotransfer of the CD45RBlo CD4+ T cell subset. Here we have dissected the mechanism of pathogenesis of IBD in this model and used this information for rational immunotherapy of the disease. CD4+ cells from diseased mice displayed a highly polarized Th1 pattern of cytokine synthesis upon polyclonal stimulation in vitro. The administration of anti-IFN gamma MAb to mice soon after T cell transfer prevented development of colitis for up to 12 weeks. Continual neutralization of TNF with anti-TNF MAbs reduced the incidence of severe disease; however, neutralization of TNF during only the first 3-4 weeks had no effect. Severe colitis was completely abrogated in mice treated systemically with rIL-10, but not with rIL-4.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Another therapeutic approach includes blocking Th1 responses or using neutralizing antibodies such as infliximab (anti-TNF) antibody.
“Another therapeutic approach includes blocking Th1 responses or using neutralizing antibodies such as infliximab (anti-TNF) antibody.189,190”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [189]
Cites
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248 · see citing works
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762 · see citing works
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888 · see citing works
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733 · see citing works
Moore, K. W., O’Garra, A., Malefyt, R. D. W., Vieira, P., & Mosmann, T. R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001121 · Cited by 1,883 · see citing works
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,858 · see citing works
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. D. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744 · see citing works
Macrophage deactivation by interleukin 10.
Bogdan, C., Yoram Vodovotz, B., & Nathan, C. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,236 · see citing works
Podolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251306 · Cited by 1,228 · see citing works
Cherwinski, H., Schumacher, J., Brown, K., & Mosmann, T. (1987) · Journal of Experimental Medicine · doi:10.1084/jem.166.5.1229 · Cited by 1,118 · see citing works
Powrie, F., Leach, M. W., Mauze, S., Caddie, L. B., & Coffman, R. L. (1993) · International Immunology · doi:10.1093/intimm/5.11.1461 · Cited by 1,078 · see citing works
Self-citationGerard, C. M., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., & Velu, T. J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.547 · Cited by 786 · see citing works
Interleukin 10 protects mice from lethal endotoxemia.
Howard, M., Muchamuel, T., Andrade, S., & Menon, S. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.4.1205 · Cited by 782 · see citing works
Self-citationInterferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.
Madara, J. L., & Stafford, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113938 · Cited by 758 · see citing works
IFN- gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.
Finkelman, F. D., Katona, I. M., Mosmann, T. R., & Coffman, R. L. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.4.1022 · Cited by 724 · see citing works
Self-citationSpontaneous development of inflammatory bowel disease in T cell receptor mutant mice
Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80069-q · Cited by 718 · see citing works
Immune interferon: a pleiotropic lymphokine with multiple effects
Trinchieri, G., & PERUSSIA, B. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90080-5 · Cited by 667 · see citing works
Powrie, F., Correa-Oliveira, R., Mauze, S., & Coffman, R. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.589 · Cited by 613 · see citing works
Self-citationCytokines in intestinal inflammation: Pathophysiological and clinical considerations
Sartor, R. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90614-9 · Cited by 595 · see citing works
Piguet, P. F., Grau, G. E., Allet, B., & VASSALLI, P. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.5.1280 · Cited by 584 · see citing works
Scott, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.3149 · Cited by 525 · see citing works
Surface Antigen Expression and Immunoglobulin Gene Rearrangement During Mouse pre‐B Cell Development
Coffman, R. L. (1983) · Immunological Reviews · doi:10.1111/j.1600-065x.1983.tb00446.x · Cited by 484 · see citing works
Self-citationMacDonald, T. T., Hutchings, P. R., CHOY, M.-Y., et al. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb03334.x · Cited by 483 · see citing works
Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse
Pennline, K. J., Roque-Gaffney, E., & Monahan, M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1068 · Cited by 428 · see citing works
Swain, S. L., Bradley, L. M., Croft, M., Tonkonogy, S. L., Atkins, G., Weinberg, A. D., Duncan, D. D., Hedrick, S. Μ., Dutton, R. W., & Huston, G. E. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00608.x · Cited by 422 · see citing works
MacDonald, T. T., & Spencer, J. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.4.1341 · Cited by 398 · see citing works
Abrams, J. S., Roncarolo, M., Yssel, H., Andersson, U., Gleich, G. J., & Silver, J. E. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01406.x · Cited by 347 · see citing works
Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo
Powrie, F. M., Menon, S., & Coffman, R. L. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230926 · Cited by 331 · see citing works
Self-citationBreese, E. J., Braegger, C., Corrigan, C. J., Walker-Smith, J. A., & MacDonald, T. T. (1993) · PubMed Central · Cited by 327 · see citing works
Wogensen, L., Lee, M. S., & Sarvetnick, N. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1379 · Cited by 291 · see citing works
Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function
Locksley, R. M., & Scott, P. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80017-9 · Cited by 272 · see citing works
Vercelli, D., Jabara, H. H., Lauener, R. P., & Geha, R. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.570 · Cited by 260 · see citing works
Brocke, S., Gaur, A., Piercy, C., Gautam, A. M., Gijbels, K., Fathman, C. G., & Steinman, L. (1993) · Nature · doi:10.1038/365642a0 · Cited by 252 · see citing works
Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.
Peleman, R. A., Wu, J., Fargeas, C. A., & Delespesse, G. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.5.1751 · Cited by 222 · see citing works
Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice
Strober, W., & Ehrhardt, R. O. (1993) · Cell · doi:10.1016/0092-8674(93)80062-j · Cited by 191 · see citing works
IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1.
Doukas, J., & Pober, J. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1727 · Cited by 172 · see citing works
Mowat, A. M. (1989) · PubMed Central · Cited by 170 · see citing works
Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
Issekutz, T. B., Stoltz, J. M., & van der Meide, P. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.2989 · Cited by 169 · see citing works
Colgan, S. P., Parkos, C. A., Delp, C., Arnaout, M. A., & Madara, J. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.120.3.785 · Cited by 163 · see citing works
Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock
Bean, A. G. D., Freiberg, R. A., Andrade, S., Menon, S., & Zlotnik, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.11.4937-4939.1993 · Cited by 162 · see citing works
Self-citationChoy, M. Y., Walker-Smith, J. A., Williams, C. B., & MacDonald, T. T. (1990) · Gut · doi:10.1136/gut.31.12.1365 · Cited by 159 · see citing works
Tanaka, T., Hu‐Li, J., Seder, R. A., Groth, B. F. D. S., & Paul, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5914 · Cited by 140 · see citing works
Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.
Cappello, M., Keshav, S., Prince, C., Jewell, D. P., & Gordon, S. (1992) · Gut · doi:10.1136/gut.33.9.1214 · Cited by 134 · see citing works
The role of tumor necrosis factor (cachectin) in cachexia
Oliff, A. (1988) · Cell · doi:10.1016/0092-8674(88)90543-0 · Cited by 115 · see citing works
Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine
van der Heijden, P. J., & Stok, W. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90285-7 · Cited by 112 · see citing works
Murphy, E., Hieny, S. E., Sher, A., & O’Garra, A. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90386-l · Cited by 94 · see citing works
Hunter, C. A., Abrams, J. S., Beaman, M. H., & Remington, J. S. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4038-4044.1993 · Cited by 89 · see citing works
CELLS AND CYTOKINES IN MUCOSAL IMMUNITY AND INFLAMMATION
Beagley, K. W., & Elson, C. O. (1992) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00035-2 · Cited by 87 · see citing works
Abrams, J. S., & Pearce, M. K. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.1.131 · Cited by 73 · see citing works
Effects of interleukin 4 on monocyte functions: comparison to interleukin 13
Malefyt, R. D. W., Figdor, C. G., & de Vries, J. E. (1993) · Research in Immunology · doi:10.1016/s0923-2494(05)80016-1 · Cited by 49 · see citing works
Inhibition of cell-mediated immunity by IL4 and IL10
Powrie, F. M., & Coffman, R. L. (1993) · Research in Immunology · doi:10.1016/s0923-2494(05)80019-7 · Cited by 41 · see citing works
Self-citationThe immunology of inflammatory bowel disease
Lowes, J. R., & Jewell, D. (1990) · Springer Seminars in Immunopathology · doi:10.1007/bf00197510 · Cited by 36 · see citing works
Overview of inflammatory bowel disease in humans.
Barkin, R. L., & Jh, L. (1992) · PubMed · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · see citing works
Self-citationIntestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · see citing works
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135 · see citing works
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059 · see citing works
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806 · see citing works
Bile acid metabolites control TH17 and Treg cell differentiation
Hang, S., Paik, D., Yao, L., Kim, E., Trinath, J., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1785-z · Cited by 1,457 · see citing works
Interleukin-23 drives innate and T cell–mediated intestinal inflammation
Hue, S., Ahern, P., Buonocore, S., Kullberg, M. C., Cua, D. J., McKenzie, B. S., Powrie, F., & Maloy, K. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061099 · Cited by 823 · see citing works
Self-citationRegulation of Intestinal Barrier Function by Microbial Metabolites
Ghosh, S., Whitley, C. S., Haribabu, B., & Jala, V. R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.02.007 · Cited by 835 · see citing works
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756 · see citing works
Bacterial flagellin is a dominant antigen in Crohn disease
Lodes, M. J., Cong, Y., Elson, C. O., Mohamath, R., Landers, C. J., Targan, S. R., Fort, M., & Hershberg, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420295 · Cited by 802 · see citing works
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560 · see citing works
Modulation of human dendritic cell phenotype and function by probiotic bacteria
Hart, A. L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M. A., Knight, S. C., & Stagg, A. J. (2004) · Gut · doi:10.1136/gut.2003.037325 · Cited by 555 · see citing works
Federici, S., Kredo-Russo, S., Valdés-Mas, R., Kviatcovsky, D., Weinstock, E., Matiuhin, Y., Silberberg, Y., Atarashi, K., Furuichi, M., Oka, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.003 · Cited by 542 · see citing works
Su, L., Shen, L., Clayburgh, D. R., Nalle, S. C., Sullivan, E. A., Meddings, J. B., Abraham, C., & Turner, J. R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.081 · Cited by 455 · see citing works
Davidson, N. J., Leach, M. W., Fort, M. M., Thompson-Snipes, L., Kühn, R., Müller, W., Berg, D. J., & Rennick, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.241 · Cited by 402 · see citing works
Self-citationReimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., & Duclos, B. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01540912 · Cited by 281 · see citing works
Contributions of the intestinal microbiome in lung immunity
McAleer, J. P., & Kolls, J. K. (2018) · European Journal of Immunology · doi:10.1002/eji.201646721 · Cited by 243 · see citing works
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis
Graham, W. V., He, W., Marchiando, A. M., Zha, J., Singh, G., Li, H.-S., Biswas, A., Ong, M. L. D. M., Jiang, Z.-H., Choi, W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0393-7 · Cited by 176 · see citing works
The mucosal immune system in the oral cavity—an orchestra of T cell diversity
Wu, R.-Q., Zhang, D.-F., Tu, E., Chen, Q.-M., & Chen, W. (2014) · International Journal of Oral Science · doi:10.1038/ijos.2014.48 · Cited by 171 · see citing works
Maseda, D., Candando, K. M., Smith, S. H., Kalampokis, I., Weaver, C. T., Plevy, S. E., Poe, J. C., & Tedder, T. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300649 · Cited by 144 · see citing works
T lymphocytes in the intestinal mucosa: defense and tolerance
Ma, H., Tao, W., & Zhu, S. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0208-2 · Cited by 125 · see citing works
CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
Nancey, S., Holvöet, S., Graber, I., Joubert, G., Philippe, D., Martin, S., Nicolas, J., Desreumaux, P., Flourié, B., & Kaiserlian, D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.018 · Cited by 112 · see citing works
Brown, I. E., Blank, C., Kline, J., Kacha, A. K., & Gajewski, T. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4521 · Cited by 91 · see citing works
Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling
Pawlak, M., DeTomaso, D., Schnell, A., Meyer zu Horste, G., Lee, Y., Nyman, J., Dionne, D., Regan, B. M. L., Singh, V., Delorey, T., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.007 · Cited by 49 · see citing works
- Authors
- Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 1994-10
- Volume
- 1
- Issue
- 7
- Pages
- 553-562
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W1971119469
- Cited by
- 1,146
- References
- 53
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 17 · 2023: 19 · 2022: 26 · 2021: 33 · 2020: 24 · 2019: 28 · 2018: 31 · 2017: 20 · 2016: 31 · 2015: 35 · 2014: 48 · 2013: 45 · 2012: 32
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- inflammatory bowel disease, Th1 cells, SCID mice, colitis, anti-IFN-gamma monoclonal antibody, TNF-alpha neutralization, IL-10, IL-4, T cell transfer, immunotherapy, cytokine polarization
- MeSH terms
- Animals, Antibodies, Monoclonal, Colitis, Colon, Interferon-gamma, Interleukins, Mice, Inbred BALB C, RNA, Messenger, Time Factors, Tumor Necrosis Factor-alpha, Inflammatory Bowel Diseases, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Mice, SCID, Leukocyte Common Antigens, Th1 Cells, Models, Immunological, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review